Browsing: acquire

Merida’s antibody-engineering platform is designed to enable precise, durable removal of disease-causing antibodies, while preserving normal immune function

CNBC Cures is proudly under AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has agreed to acquire Alesta Therapeutics in a deal worth up to $490 million, adding a clinical-stage oral therapy for hypophosphatasia to its rare disease pipeline and expanding its investment in skeletal conditions

Johnson & Johnson has entered a collaboration and equity investment agreement with Sail Biomedicines, a Flagship Pioneering company, to advance in vivo CAR T-cell therapies for immune-mediated diseases. As part of the agreement, Johnson & Johnson secured an exclusive option to acquire Sail for $2.58 billion. The companies will jointly advance Sail's lead in vivo…

The Farmer’s Dog has announced it is acquiring Woof, a pet products company focused on functional enrichment and wellness. The transaction will expand The Farmer’s Dog beyond its core fresh dog food business and create a broader pet wellness platform combining nutrition, enrichment, play, and other products designed to support dogs throughout their lives

Samsonite Group S.A. has agreed to acquire an 85% stake in BÉIS in a transaction valuing the digitally native lifestyle and travel brand at approximately $210 million, giving the global luggage company greater exposure to younger consumers, lifestyle bags and direct-to-consumer commerce

This is a paid press release. Contact the press release distributor directly with any enquiries.

CNBC Cures is proudly under AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases

Adds ABS-1230, a clinical-stage, potential first-in-class precision therapy for KCNT1+ epilepsy

Cincinnati, OH—P&G announced its intention to acquire Thorne, a science-driven wellness company known for its quality dietary supplements and personalized health solutions backed by health care practitioners